Trial Details

TERMINATED
Basic Information
Clinical ID c1487
Identifier NCT04974099
Trial Title Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Crohn Disease
Interventions DEVICE: RoadMAB precision dashboard|DRUG: Infliximab precision dosing
Participant Information
Sponsor Children's Hospital Medical Center, Cincinnati
City Cincinnati
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2021-10-01
Primary Completion Date 2024-08-01
Completion Date 2024-08-01